CEBP http://www.aacr.org/default.aspx?p=2638 http://www.aacr.org/page3233.aspx
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Full Text
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Cited by other online articles
PubMed
PubMed Citation
Articles by Rinaldi, S.
Articles by Kaaks, R.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 1065-1071, October 2002
© 2002 American Association for Cancer Research

Validity of Free Testosterone and Free Estradiol Determinations in Serum Samples from Postmenopausal Women by Theoretical Calculations

Sabina Rinaldi, Annabelle Geay, Henri Déchaud, Carine Biessy, Anne Zeleniuch-Jacquotte, Arslan Akhmedkhanov, Roy E. Shore, Elio Riboli, Paolo Toniolo and Rudolf Kaaks1

IARC, Unit of Nutrition and Cancer, 69500 Lyon, France [S. R., C. B., E. R., R. K.]; Service de Radioanalyse et Radiopharmacie, Hôpital Neuro-cardiologique, Hospices Civils de Lyon, Lyon, France [A. G., H. D.]; and Departments of Environmental Medicine [A. Z-J., A. A., R. E. S., P. T.] and Obstetrics and Gynecology [A. A., P. T.], New York University School of Medicine, New York, New York 10010

In this study, we validated measurements of free testosterone (fT) and free estradiol (fE2) concentrations calculated from total serum concentrations of testosterone (T), estradiol (E2), and sex hormone-binding globulin (SHBG), measured by direct, commercial radioimmunoassays, by comparison with reference measurements obtained by dialysis plus an in-house radioimmunoassay after extraction and chromatographic purification. The study was conducted in serum samples from 19 postmenopausal women who were part of an ongoing prospective cohort study. We also performed sensitivity analyses to examine the robustness of the theoretical calculations. Sensitivity analyses showed that in this population, competitive binding of dihydrotestosterone and total T could be ignored in the calculation of fE2, and competitive binding by dihydrotestosterone does not need to be taken into account for calculation of fT. Furthermore, variations in albumin and SHBG concentrations had negligible effects on fT and fE2 calculations. Values of fT and fE2, calculated from total T and E2 concentrations obtained by the same in-house radioimmunoassay used for the dialysis method, correlated highly with the measurements by dialysis (Pearson’s coefficients of correlation above 0.97). When calculating fT and fE2 using total T and total E2 concentrations obtained by different direct radioimmunoassays, almost all kits gave good correlations with the reference method for fT (Pearson’s r > 0.83), but only a few gave good correlations for fE2 (Diagnostic System Laboratories and DiaSorin; r > 0.80). The direct radioimmunoassays giving the best correlation for fT and fE2 with the dialysis method were those that best measured total concentrations of T and E2. Furthermore, mean values of fT and fE2 corresponded well to mean values by the reference method if SHBG measurements were also well calibrated. We conclude that in postmenopausal women, theoretical calculations are valid for the determination of fT and fE2 concentrations and can give reliable estimation of cancer risk in epidemiological studies when the total concentrations of T, E2, and SHBG are measured accurately.




This article has been cited by other articles:


Home page
Am. J. Physiol.Home page
I. M. Dick, A. Devine, J. Beilby, and R. L. Prince
Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E430 - E435.
[Abstract] [Full Text] [PDF]


Home page
J Clin Endocrinol MetabHome page
A. Bjornerem, B. Straume, M. Midtby, V. Fonnebo, J. Sundsfjord, J. Svartberg, G. Acharya, P. Oian, and G. K. R. Berntsen
Endogenous Sex Hormones in Relation to Age, Sex, Lifestyle Factors, and Chronic Diseases in a General Population: The Tromso Study
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6039 - 6047.
[Abstract] [Full Text] [PDF]


Home page
J Clin Endocrinol MetabHome page
B. O. Yildiz, K. S. Woods, F. Stanczyk, A. Bartolucci, and R. Azziz
Stability of Adrenocortical Steroidogenesis over Time in Healthy Women and Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5558 - 5562.
[Abstract] [Full Text] [PDF]


Home page
Clin ChemHome page
K. Van Uytfanghe, D. Stockl, J. M. Kaufman, T. Fiers, H. A. Ross, A. P. De Leenheer, and L. M. Thienpont
Evaluation of a Candidate Reference Measurement Procedure for Serum Free Testosterone Based on Ultrafiltration and Isotope Dilution-Gas Chromatography-Mass Spectrometry
Clin. Chem., November 1, 2004; 50(11): 2101 - 2110.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol Biomarkers PrevHome page
J. Chubak, S. S. Tworoger, Y. Yasui, C. M. Ulrich, F. Z. Stanczyk, and A. McTiernan
Associations between Reproductive and Menstrual Factors and Postmenopausal Sex Hormone Concentrations
Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1296 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol Biomarkers PrevHome page
A. McTiernan, S. S. Tworoger, K. B. Rajan, Y. Yasui, B. Sorenson, C. M. Ulrich, J. Chubak, F. Z. Stanczyk, D. Bowen, M. L. Irwin, R. E. Rudolph, J. D. Potter, and R. S. Schwartz
Effect of Exercise on Serum Androgens in Postmenopausal Women: A 12-Month Randomized Clinical Trial
Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1099 - 1105.
[Abstract] [Full Text] [PDF]


Home page
Cancer ResHome page
A. McTiernan, S. S. Tworoger, C. M. Ulrich, Y. Yasui, M. L. Irwin, K. B. Rajan, B. Sorensen, R. E. Rudolph, D. Bowen, F. Z. Stanczyk, J. D. Potter, and R. S. Schwartz
Effect of Exercise on Serum Estrogens in Postmenopausal Women: A 12-Month Randomized Clinical Trial
Cancer Res., April 15, 2004; 64(8): 2923 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol Biomarkers PrevHome page
S. S. Tworoger, J. Chubak, E. J. Aiello, C. M. Ulrich, C. Atkinson, J. D. Potter, Y. Yasui, P. L. Stapleton, J. W. Lampe, F. M. Farin, F. Z. Stanczyk, and A. McTiernan
Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 94 - 101.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol Biomarkers PrevHome page
Endogenous Hormones and Breast Cancer Collaborativ
Free Estradiol and Breast Cancer Risk in Postmenopausal Women: Comparison of Measured and Calculated Values
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1457 - 1461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.